Double-blind, randomized trial of polyvalent antivenoms for snakebite in Sub-Saharan Africa
Principal investigator
-
Location
-
Methodology
-
ReferenceOCA020-55
Purpose of study
Purpose of study
The trial is expected to provide new effective and safe antivenom treatments for Sub-Saharan Africa, as well as an important model for the evaluation of antivenoms in the future. It will also provide a capstone experience for the MSF public positi...
-
Concept
-
Protocol & ERB
-
Implementation
-
Completion
-
Archived
Study timeline
-
Delivery update added by Holly Baker
10th August 2022- Data collection: Major problems or delays
- Data analysis: Not started
- Data analysis: Not started
-
Description:
Further development of the intersectional antivenom RCT has been put on hold, due to the situation in Abdurafi/Ethiopia, and insecurity in the OCG site in South Sudan.
-
Concept paper added by Jodie Pearlman
16th September 2020Study_concept_paper_Intersectional_Snakebite_Randomised_Clinical_Trial.docx68.4 KB -
Concept16th September 2020
-
Study created
16th September 2020
Publications
No publications recorded